4
Changes in Ownership
Maze Therapeutics, Inc. Filed Acc 0001415889-25-022301
Options or other derivatives
- Director acquired 16,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Exter Neil Director | 2025-08-17 | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | D: show line 1 in the form |
Loading xslF345X05/form4-08192025_080831.xml…